Dihydrofolic Acid

Dihydrofolic Acid

SCHEMBL1880562

Nc1nc2c(c(=O)[nH]1)N=C(CNc1ccc(C(=O)NC(CCC(=O)O)C(=O)O)cc1)CN2.Nc1nc2ncc(CNc3ccc(C(=O)NC(CCC(=O)O)C(=O)O)cc3)nc2c(=O)[nH]1

nearest known ligand 0.78

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ TYMS P04818 2/20 0.78
▸ KDM4E B2RXH2 1/20 0.78
▸ MEN1 O00255 1/20 0.78
▸ ALDH1A1 P00352 1/20 0.78
▸ POLB P06746 1/20 0.78
▸ GAA P10253 1/20 0.78
▸ AKR1B1 P15121 1/20 0.78
▸ HPGD P15428 1/20 0.78
▸ TSHR P16473 1/20 0.78
▸ PTGS2 P35354 1/20 0.78
▸ KMT2A Q03164 1/20 0.78
▸ HSD17B10 Q99714 1/20 0.78
▸ TDP1 Q9NUW8 1/20 0.78
▸ ADORA3 P0DMS8 1/20 0.59
▸ DHFR P00374 3/20 0.55
▸ GART P22102 3/20 0.55
▸ ATIC P31939 2/20 0.55
▸ SOST Q9BQB4 1/20 0.52
▸ MTHFD1 P11586 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dihydrofolic Acid SCHEMBL7522026 0.92 TYMS (0.66) TYMSKDM4EMEN1ALDH1A1POLB
Dihydrofolic Acid SCHEMBL8281 0.90 SOST (0.61) TYMSKDM4EMEN1ALDH1A1POLB
Dihydrofolic Acid SCHEMBL27589172 0.90 SOST (0.61) TYMSKDM4EMEN1ALDH1A1POLB
Dihydrofolic Acid SCHEMBL8282 0.90 SOST (0.61) TYMSKDM4EMEN1ALDH1A1POLB
Folic Acid SCHEMBL38662929 0.90 TYMS (0.97) TYMSKDM4EMEN1ALDH1A1POLB
Dihydrofolic Acid SCHEMBL12136386 0.90 SOST (0.61) TYMSKDM4EMEN1ALDH1A1POLB
Dihydrofolic Acid SCHEMBL27415499 0.89 SOST (0.60) TYMSKDM4EMEN1ALDH1A1POLB
Dihydrofolic Acid SCHEMBL27779274 0.89 SOST (0.60) TYMSKDM4EMEN1ALDH1A1POLB
Folic Acid SCHEMBL5365896 0.89 TYMS (0.97) TYMSKDM4EMEN1ALDH1A1POLB
Folic Acid SCHEMBL332170 0.89 TYMS (1.00) TYMSKDM4EMEN1ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7947662-B2 Folates, compositions and uses thereof GNOSIS S.P.A. (IT) 2011-05-24 — — US claimed
US-20160207925-A1 L-METHYLFOLATE SALT PREPARATIONS, MEDICAMENTS, AND NUTRITIONAL SUPPLEMENTS COMPRISING SUCH SALTS THEREOF FRACCHIA GIANNI (AU) 2016-07-21 — — US disclosed
EP-2245032-B1 FOLATES, COMPOSITIONS AND USES THEREOF GNOSIS SPA (IT) 2015-03-25 — — EP disclosed
EP-2245032-A1 FOLATES, COMPOSITIONS AND USES THEREOF Gnosis S.p.A. (IT) 2010-11-03 — — EP disclosed
WO-2009103334-A1 FOLATES, COMPOSITIONS AND USES THEREOF GNOSIS S.P.A. (IT) 2009-08-27 — — WO disclosed
US-5624564-A Process for dehydration and concentration of sewage sludge BLUM HOLGER (DE) 1997-04-29 — — US disclosed
US-4956092-A Method for concentrating/dehydrating of sewage sludge BLUM HOLGER (DE) 1990-09-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160207925-A1 L-METHYLFOLATE SALT PREPARATIONS, MEDICAMENTS, AND NUTRITIONAL SUPPLEMENTS COMPRISING SUCH SALTS THEREOF DHFR, MTHFD1, BHMT2 TYMS 80/4885KDM4E 455/4885MEN1 775/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback